MRgFUS is a non-invasive outpatient treatment for uterine myomas that uses high-intensity focused ultrasound pulses to destroy fibroid tissue. Guided by real-time MRI for precision, the procedure heats target cells to 60°C–85°C, causing thermal ablation while preserving the surrounding healthy uterine tissue and future fertility.
- Treatment mechanism: Ultrasound pulses cause coagulative necrosis by heating fibroids without any surgical incisions.
- MRI guidance: Real-time 3D imaging monitors tissue temperature to prevent damage to the bladder.
- Rapid recovery: Patients usually return to daily activities within 1 to 3 days post-procedure.
- Uterine preservation: The uterus remains intact, making it an alternative to hysterectomy or myomectomy.
Bookimed Expert Insight: Italian clinics specializing in women's health often integrate advanced ultrasound diagnostics with surgical expertise. For example, Ospedale Santa Maria in Bari couples ultrasound centers with major surgical departments. This allows doctors to transition patients from non-invasive FUS-ablation to robotic surgery if fibroid size exceeds 10 centimeters.
Patient Consensus: Patients value how this technology provides relief from symptoms like heavy bleeding without the risks of blood transfusions. Many appreciate avoiding general anesthesia and the ability to return home the same day.